Evidence map›Paper›PMID 42527443›Full record

ArticleScientific reports2026

Localized delivery of coding nucleic acids into adherent cells by in situ electroporation: integrated impedance-based monitoring allows for loss-of-function or gain-of-function screening.

Anne-Kathrin Grimm, Sonja Balk, Achim Göpferich, Miriam Breunig, Simone Aubele, Anne Zemella, Joachim Wegener

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Anne-Kathrin Grimm *Institut für Analytische Chemie, Chemo- und Biosensorik, Universität Regensburg, Regensburg, Germany.
Sonja Balk *Institut für Analytische Chemie, Chemo- und Biosensorik, Universität Regensburg, Regensburg, Germany.
Achim GöpferichInstitut für Pharmazie, Universität Regensburg, Regensburg, Germany.
Miriam BreunigInstitut für Pharmazie, Universität Regensburg, Regensburg, Germany.
Simone AubeleInstitutsteil Bioanalytik und Bioprozesse, Fraunhofer-Institut für Zelltherapie und Immunologie, Potsdam, Germany.
Anne ZemellaInstitutsteil Bioanalytik und Bioprozesse, Fraunhofer-Institut für Zelltherapie und Immunologie, Potsdam, Germany.
Joachim WegenerInstitut für Analytische Chemie, Chemo- und Biosensorik, Universität Regensburg, Regensburg, Germany. Joachim.Wegener@emft.fraunhofer.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coding nucleic acids (NAs) like DNA, mRNA or siRNA hold endless potential to engineer cells with respect to their genome and proteome. However, minimally invasive delivery of NAs across an intact plasma membrane into the cytosol of living cells remains a technical challenge. Electroporation creates transient pores in the plasma membrane by applying well-defined electric fields for fractions of a second allowing NA transfer across the membrane. In situ electroporation (ISE) applies the electric field to adherent cells growing on the surface of planar, thin-film electrodes deposited on the bottom of the culture well. This study reports on the localized delivery of plasmid DNA, mRNA, siRNA and aptamers into different mammalian cell lines by ISE. Fluorescence microscopy verified successful delivery of labeled NAs themselves (siRNA, aptamers) or expression of the proteins they encoded (DNA, mRNA). Impedance readings of the cell-covered electrodes before and after ISE allowed tracking the invasiveness of the pulse, the recovery of the cells within 30 min and the phenotypic impact of the NAs inside the cells. Loading the cells with siRNA specifically designed to knock down gene transcripts essential for survival, led to the onset of cell death within 20 h after the pulse. The combination of ISE, specific NAs and impedance-based cell monitoring paves the way for a new class of gain-of-function or loss-of-function experiments.

Indexed as

ElectroporationNucleic AcidsAnimalsAptamers, NucleotideCell AdhesionCell LineDNAElectric ImpedanceElectroporation TherapiesGene Transfer TechniquesHumansPlasmidsRNA, MessengerRNA, Small InterferingAptamers, NucleotideDNANucleic AcidsRNA, MessengerRNA, Small InterferingElectric cell-substrate impedance sensing (ECIS)Gain-of-functionIn situ electroporation (ISE)Intracellular deliveryLoss-of-functionPhenotypic assays

Identifiers

PMID42527443
PMCPMC13421483

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.